Show simple item record

 
dc.contributorVall d'Hebron Barcelona Hospital Campus
dc.contributor.authorGarcia-Cehic, Damir
dc.contributor.authorCampos, Carolina
dc.contributor.authorIbañez Lligoña, Marta
dc.contributor.authorColomer-Castell, Sergi
dc.contributor.authorGregori Font, Josep
dc.contributor.authorPiñana, María
dc.contributor.authorGonzález-Sánchez, Alejandra
dc.contributor.authorRando Segura, Ariadna
dc.contributor.authorEsperalba, Juliana
dc.contributor.authorSaubi, Narcis
dc.contributor.authorCortese, Maria Francesca
dc.contributor.authorTabernero, David
dc.contributor.authorFerrer Costa, Roser
dc.contributor.authorEsteban Mur, Juan Ignacio
dc.contributor.authorPumarola Suñe, Tomàs
dc.contributor.authorQUER, JOSEP
dc.contributor.authorAntón Pagarolas, Andrés
dc.contributor.authorAndrés Vergés, Cristina
dc.date.accessioned2025-09-25T07:44:15Z
dc.date.available2025-09-25T07:44:15Z
dc.date.issued2025-07
dc.identifier.citationCampos C, Ibañez-Lligoña M, Colomer‑Castell S, Gregori J, Garcia‑Cehic D, Andrés C, et al. Deep Sequencing Reveals Dual Evolution of SARS-CoV-2: Insights Into Defective Genomes From Wuhan-Hu-1 Variants to Omicron Subvariants. J Med Virol. 2025 Jul;97(7):e70476.
dc.identifier.issn1096-9071
dc.identifier.urihttp://hdl.handle.net/11351/13722
dc.descriptionOmicron; Deep‐sequencing; Dual evolution
dc.description.abstractSARS-CoV-2 has evolved from early variants dominating the first (B.1.5, B.1.1) and second (B.1.177) pandemic waves, which exhibited a higher frequency of minority mutants with deletions leading to Defective Viral Genomes (DVGs) in the spike region near the S1/S2 cleavage site than the Alpha, Beta, and Delta variants. The emergence of Omicron has significantly altered the dominant variant profile, with Omicron subvariants now representing 100% of circulating viruses. To monitor the evolution and adaptation of Omicron in the human population, a deep-sequencing study was performed in RNA samples of BA.1, BA.1.1, BA.2, BA.5, BQ.1.1, XBB.1.5 and BA.2.86 Omicron subvariants. The findings reveal two occurrences of similar evolutionary patterns within SARS-CoV-2 characterized by a shift from a significant to a very low production of DVGs. This event suggests that DVGs might play a role in the virus's spread and adaptation for persistence in infected humans.
dc.language.isoeng
dc.publisherWiley
dc.relation.ispartofseriesJournal of Medical Virology;97(7)
dc.rightsAttribution 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.sourceScientia
dc.subjectCOVID-19 (Malaltia)
dc.subjectAnomalies cromosòmiques
dc.subjectGenomes
dc.subjectSeqüència de nucleòtids
dc.subject.meshCoronavirus Infections
dc.subject.meshMutation
dc.subject.meshGenome, Viral
dc.subject.meshHigh-Throughput Nucleotide Sequencing
dc.titleDeep Sequencing Reveals Dual Evolution of SARS-CoV-2: Insights Into Defective Genomes From Wuhan-Hu-1 Variants to Omicron Subvariants
dc.typeinfo:eu-repo/semantics/article
dc.identifier.doi10.1002/jmv.70476
dc.subject.decsinfecciones por Coronavirus
dc.subject.decsmutación
dc.subject.decsgenoma viral
dc.subject.decssecuenciación de nucleótidos de alto rendimiento
dc.relation.publishversionhttps://doi.org/10.1002/jmv.70476
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dc.audienceProfessionals
dc.contributor.organismesInstitut Català de la Salut
dc.contributor.authoraffiliation[Campos C, Colomer Castell S, Esteban JI, Quer J] Grup de Recerca de les Malalties Hepàtiques, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Servei d’Hepatologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, Madrid, Spain. Biochemistry and Molecular Biology Department, Universitat Autònoma de Barcelona (UAB), Bellaterra, Spain. [Ibañez‐Lligoña M] Grup de Recerca de les Malalties Hepàtiques, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Servei d’Hepatologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, Madrid, Spain. Medicine Department, Universitat Autònoma de Barcelona (UAB), Bellaterra, Spain. [Gregori J] Grup de Recerca de les Malalties Hepàtiques, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Servei d’Hepatologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, Madrid, Spain. [Garcia Cehic D] Grup de Recerca de les Malalties Hepàtiques, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Servei d’Hepatologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, Madrid, Spain. Department of Radiation Oncology, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA. [Andrés C, Piñana M, González Sánchez A] Unitat de Virus Respiratoris, Servei de Microbiologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. CIBER of Infectious Diseases (CIBERINFEC) Instituto de Salud Carlos III, Madrid, Spain. [Rando Segura A] Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, Madrid, Spain. Unitat de Virus Respiratoris, Servei de Microbiologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Servei de Microbiologia, Vall d'Hebron Hospital Universitari, Barcelona, Spain. [Esperalba J, Saubí N] Unitat de Virus Respiratoris, Servei de Microbiologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Servei de Microbiologia, Vall d'Hebron Hospital Universitari, Barcelona, Spain. [Cortese MF] Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, Madrid, Spain. Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Servei de Microbiologia, Vall d'Hebron Hospital Universitari, Barcelona, Spain. [Tabernero D] Grup de Recerca de les Malalties Hepàtiques, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Servei d’Hepatologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, Madrid, Spain. Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Servei de Microbiologia, Vall d'Hebron Hospital Universitari, Barcelona, Spain. [Ferrer R] Servei de Bioquímica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Grup de Bioquímica Clínica, Vehiculització de Fàrmacs i Teràpia, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Pumarola T, Antón A] Unitat de Virus Respiratoris, Servei de Microbiologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. CIBER of Infectious Diseases (CIBERINFEC) Instituto de Salud Carlos III, Madrid, Spain. Microbiology Department, Universitat Autònoma de Barcelona (UAB), Bellaterra, Spain
dc.identifier.pmid40586690
dc.identifier.wos001519750000001
dc.relation.projectidinfo:eu-repo/grantAgreement/ES/PEICTI2021-2023/PID2021-126447OB-I00
dc.relation.projectidinfo:eu-repo/grantAgreement/ES/PE2017-2020/PI19%2F00301
dc.relation.projectidinfo:eu-repo/grantAgreement/ES/PE2017-2020/PI19%2F00533
dc.relation.projectidinfo:eu-repo/grantAgreement/ES/PEICTI2021-2023/PI22%2F00258
dc.relation.projectidinfo:eu-repo/grantAgreement/ES/PEICTI2021-2023/PI22%2F00023
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record